Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Cotrimoxazole

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Santos PG, et al. EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, WHAT TO EXPECT IN THE FUTURE?. European Journal of Case Reports in Internal Medicine 8 (Suppl. 1): 252 abstr. PV621, Jan 2021. Available from: URL: https://dx.doi.org/10.12890/2021_V8Sup1 [abstract] Santos PG, et al. EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, WHAT TO EXPECT IN THE FUTURE?. European Journal of Case Reports in Internal Medicine 8 (Suppl. 1): 252 abstr. PV621, Jan 2021. Available from: URL: https://dx.doi.org/10.12890/2021_V8Sup1 [abstract]
Metadaten
Titel
Cotrimoxazole
Lack of efficacy
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54440-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Ticagrelor

Case report

Zoledronic-acid

Case report

Multiple drugs

Case report

Mitomycin